The outbreak of COVID-19 generated an unprecedented reaction in both financial markets and economies worldwide. The uncertainty that followed created significant challenges when performing valuation analyses and estimating cost of capital inputs in the aftermath of the pandemic.
To help finance and valuation professionals navigate the uncertainty, we launched an infographic series tracking the impact of COVID-19 on some of the financial market and economic indicators used to support Kroll’s recommendations for cost of capital inputs, such as equity risk premiums and accompanying normalized risk-free rates.
Click on the Infographic to Open the PDF
Provides size premia, risk premia, equity risk premia, risk-free rates, betas and industry risk premia that can be used to estimate U.S. cost of capital.